Der neue Bericht
zum europäischen
e-Pharmacy-Markt 2024

What Europe needs now for a networked supply of medicines​

While nearly all EU Member States have now introduced e-prescriptions, access to prescription medicines through digital channels remains highly uneven across Europe. 8 out of 27 Member States (in addition to UK, Switzerland, Iceland, and Norway) – including Germany, Sweden, Denmark,, the Netherlands, Portugal, Lithuania, Estonia and Finland – currently allow prescription medicines to be dispensed online. In contrast, 19 of the Member States still prohibit the online sale and home delivery of Rx medicines, creating a fragmented landscape that limits patient access and undermines the full potential of digital health innovation.

This fragmented landscape is also clearly reflected in our analysis across the 13 markets: wherever robust legal frameworks and digital infrastructure are in place, the e-pharmacy market grows dynamically. In Poland, for instance, growth exceeds the average with 16%, driven by new regulations enabling remote treatment. In contrast, patient access in France, Italy, Belgium, and Austria remains limited, despite the necessary technical infrastructure being available. Later in this report, we will compare these developments in more detail and highlight what lessons can be learned across countries.

What Europe needs now for a networked supply of medicines​

While nearly all EU Member States have now introduced e-prescriptions, access to prescription medicines through digital channels remains highly uneven across Europe. 8 out of 27 Member States (in addition to UK, Switzerland, Iceland, and Norway) – including Germany, Sweden, Denmark,, the Netherlands, Portugal, Lithuania, Estonia and Finland – currently allow prescription medicines to be dispensed online. In contrast, 19 of the Member States still prohibit the online sale and home delivery of Rx medicines, creating a fragmented landscape that limits patient access and undermines the full potential of digital health innovation.

This fragmented landscape is also clearly reflected in our analysis across the 13 markets: wherever robust legal frameworks and digital infrastructure are in place, the e-pharmacy market grows dynamically. In Poland, for instance, growth exceeds the average with 16%, driven by new regulations enabling remote treatment. In contrast, patient access in France, Italy, Belgium, and Austria remains limited, despite the necessary technical infrastructure being available. Later in this report, we will compare these developments in more detail and highlight what lessons can be learned across countries.

remains restricted despite the technical capabilities being in place. Later in this report, we will compare these developments in more detail and highlight what lessons can be learned across countries.